SecBot SecBot
6-K ·Filed Aug 3, 2026

INMD

InMode Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001178913-26-003752
Notable filing: 6-K
Actionable Insight • Neutral

No trading implications from this routine governance filing. Monitor next quarterly earnings release or material 6-K for any operational or financial updates.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
INMD ▼ -2.54% at T+20d
NEUTRAL call -2.54% · α vs SPY -3.78% · entry $15.35 → $14.96
Next anchor: T+60d due just now
Latest observation: T+58 -10.24% FF3 residual α
Entry = T+0 close
Aug 3, 2026
via day close
T+1d
+0.13%
call +0.13% · α -1.67%
$15.37
settled 3mo ago
T+5d
-1.04%
call -1.04% · α -3.07%
$15.19
settled 3mo ago
T+20d
-2.54%
call -2.54% · α -3.78%
$14.96
settled 8w ago
T+60d
Pending
due just now

Price Chart

Loading chart...

Executive Summary

InMode Ltd. filed a 6-K reporting the results of its Annual General Meeting held July 30, 2026, where shareholders approved all four proposals: re-election of Dr. Hadar Ron as Class I director, re-appointment of Kesselman & Kesselman (PwC) as auditors, grant of 6,000 restricted share units to non-executive directors, and compensation terms for the Special Committee. The vote was routine with 54.71% quorum, no material financial or operational information was disclosed.

Key Facts

  • Annual General Meeting held July 30, 2026; all four proposals approved
  • Quorum of 31,479,861 shares out of 57,544,172 outstanding (54.71%)
  • Re-elected Dr. Hadar Ron as Class I director until 2029 AGM
  • Re-appointed Kesselman & Kesselman (PwC Israel) as independent auditors for FY2026
  • Granted 6,000 RSUs total (2,000 each) to non-executive directors Dr. Shlomo Nass, Dr. Hadar Ron, and Mr. Nadav Kenneth, vesting in two tranches on Feb 15, 2027 and Feb 15, 2028

Financial Impact

No financial metrics disclosed; routine governance filing with immaterial RSU grant of 6,000 shares (less than 0.01% of outstanding)

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
50% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-003752
Document: 0001178913-26-003752-index-headers.html0001178913-26-003752
Document: 0001178913-26-003752-index.html0001178913-26-003752
Document: 0001178913-26-003752.txt0001178913-26-003752
11 reports for INMD
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +7.66%Jul 13, 2026
Filters
Rows
Reports for INMD — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
6-K
NEUTRAL ★ 3/10
$14.16awaiting T+20—$13.72 (−3.11%)
Oct 21, 2026
5d ago
SC 13D/A
NEUTRAL ★ 4/10
$14.03awaiting T+20—$13.72 (−2.21%)
Oct 13, 2026
14d ago
Press Release
NEUTRAL ★ 5/10
$14.31awaiting T+20—$13.72 (−4.09%)
Sep 16, 2026
5w ago
6-K
BEARISH ★ 6/10
$14.58 $14.31▲ +1.89%▲ +5.06%$13.72 (+5.90%)
Aug 5, 2026
11w ago
6-K
BEARISH ★ 6/10
$15.21 $14.95▲ +1.71%▲ +1.11%$13.72 (+9.80%)
Aug 3, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$15.35 $14.96▼ −2.54%▼ −3.78%$13.72 (−10.62%)
Jul 20, 2026
14w ago
6-K
BULLISH ★ 6/10
$15.36 $14.99▼ −2.41%▼ −4.97%$13.72 (−10.68%)
Jul 13, 2026
15w ago
6-K
BEARISH ★ 6/10
$15.15 $15.19▼ −0.26%▲ +2.92%$13.72 (+9.44%)
Jul 10, 2026
15w ago
6-K
BULLISH ★ 7/10
$15.28 $15.31▲ +0.20%▼ −2.23%$13.72 (−10.21%)
Jun 25, 2026
17w ago
6-K
BEARISH ★ 6/10
$14.63 $15.09▼ −3.14%▼ −1.88%$13.72 (+6.22%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 1h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026